BayCare fits proton therapy into a conventional radiation vault, but can the model scale?
BayCare begins upright proton therapy using Mevion S250-FIT and Leo's Marie system, testing a compact model for expanding cancer treatment access.
Medical Devices & Diagnostics
Medical Devices & Diagnostics
BayCare’s $33m proton centre fits inside a conventional radiation vault. Could this change cancer care economics?
BayCare begins treatments at its $33 million Tampa proton centre using Mevion S250-FIT. Examine the clinical benefits and hospital economics.
Medical Devices & Diagnostics
Leo Cancer Care targets proton therapy access with $65m Series D financing
Leo Cancer Care has raised $65 million in Series D financing to scale its integrated upright cancer care platform, which is designed to image and treat patients in a seated position rather than the conventional lying-down setup. The oversubscribed round supports manufacturing scale-up, commercial deployment and continued development across upright proton therapy, photon therapy and
Medical Devices & Diagnostics
Mevion’s European expansion gains momentum with Southern Italy proton therapy project
Proton therapy is precise but hard to scale. Mevion’s Naples win tests whether compact systems can shift access across Southern Europe.
Medical Devices & Diagnostics
Can Mevion’s S250-FIT make proton therapy practical for more cancer centers?
Proton therapy has long had an infrastructure problem. Mevion’s S250-FIT asks whether existing LINAC vaults can change that.